At present, neither TP53 nor ATM alteration are used routinely to guide RT utilization; however, MCL can be extremely sensitive to very low dose radiation (128), and therefore, a relationship between MCL’s altered DDR and radiosensitivity may exist. The gene discussed is TP53; the disease is mantle cell lymphoma.